Trial intelligence / Profile preview

Vuloven as Adjunctive Therapy for Internal Carotid Artery Hypoperfusion

NCT01192581Phase 2Unknown

Sponsor
Xijing Hospital
Start
Aug 2010
Primary completion
Apr 2011
Countries
1
01

Overview

A Phase 2 trial of Volulyte in Cerebral hypoperfusion, sponsored by Xijing Hospital. Status: unknown.

02

Drugs

Volulyte
03

Conditions

Cerebral hypoperfusion

Beyond the preview

Go deeper on NCT01192581.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01192581.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call